NDC11 00054025413
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00054-0254-13 | 00054-0254 |
| 00054-254-13 | 00054-254 |
| 0054-0254-13 | 0054-0254 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Hikma Pharmaceuticals USA Inc. | 17561aae-f0bc-4ffc-a007-985b17e9baf0 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | 0054-0254-13 0054-0254 00054025413 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.